Total Payments
$616.34
2024 Payments
$257.15
Companies
12
Transactions
28
Medicare Patients
10,782
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$616.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $616.34 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $171.57 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $127.29 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $69.96 | 3 | $0 (2024) |
| AbbVie Inc. | $49.78 | 2 | $0 (2021) |
| PFIZER INC. | $46.42 | 2 | $0 (2023) |
| Amgen Inc. | $38.00 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31.13 | 1 | $0 (2024) |
| Organogenesis Inc. | $19.36 | 1 | $0 (2017) |
| Lilly USA, LLC | $18.98 | 1 | $0 (2017) |
| Journey Medical Corporation | $16.89 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.15 | 11 | E.R. Squibb & Sons, L.L.C. ($69.96) |
| 2023 | $171.24 | 8 | GENZYME CORPORATION ($84.38) |
| 2022 | $47.57 | 2 | GENZYME CORPORATION ($26.53) |
| 2021 | $49.35 | 2 | PFIZER INC. ($26.13) |
| 2020 | $26.56 | 1 | AbbVie Inc. ($26.56) |
| 2019 | $12.16 | 1 | Allergan Inc. ($12.16) |
| 2017 | $52.31 | 3 | Organogenesis Inc. ($19.36) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Immunology | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
| 11/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Immunology | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.16 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Dermatology | ||||||
| 05/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Inflammation | ||||||
| 04/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.08 | General |
| Category: Immunology | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Immunology | ||||||
| 02/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Immunology | ||||||
| 01/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.41 | General |
| Category: Immunology | ||||||
| 09/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Immunology | ||||||
| 06/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 05/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Immunology | ||||||
| 04/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Immunology | ||||||
| 04/04/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, COMIRNATY | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DERMATOLOGY | ||||||
| 03/27/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $16.89 | General |
| 02/21/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
| 02/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 11/08/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Immunology | ||||||
| 11/03/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Immunology | ||||||
| 09/08/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: DERMATOLOGY | ||||||
| 02/24/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,034 | 6,920 | $742,118 | $331,849 |
| 2022 | 22 | 2,900 | 6,741 | $885,387 | $326,345 |
| 2021 | 26 | 2,728 | 6,017 | $853,487 | $346,482 |
| 2020 | 26 | 2,120 | 4,460 | $558,013 | $214,204 |
Total Patients
10,782
Total Services
24,138
Medicare Billing
$1.2M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 612 | 920 | $137,801 | $61,975 | 45.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 481 | 792 | $91,510 | $35,778 | 39.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 266 | 366 | $72,744 | $33,966 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 328 | $69,123 | $32,286 | 46.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 298 | 382 | $68,519 | $30,159 | 44.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 31 | 34 | $39,668 | $19,634 | 49.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 393 | 3,210 | $40,776 | $18,550 | 45.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 74 | 122 | $36,009 | $17,582 | 48.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 26 | 30 | $32,887 | $15,288 | 46.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 213 | 283 | $27,212 | $12,345 | 45.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 47 | $24,759 | $10,735 | 43.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 36 | 38 | $17,361 | $6,945 | 40.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 14 | 17 | $12,174 | $6,323 | 51.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 44 | $18,354 | $4,941 | 26.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 75 | 103 | $8,959 | $4,566 | 51.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $10,362 | $4,041 | 39.0% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 11 | $7,515 | $3,928 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,662 | $3,748 | 48.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 53 | 53 | $6,411 | $3,226 | 50.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 17 | $3,730 | $1,892 | 50.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $3,377 | $1,664 | 49.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 12 | $2,580 | $1,146 | 44.4% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 16 | $2,624 | $1,132 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 573 | 877 | $131,550 | $62,290 | 47.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 429 | 770 | $96,250 | $36,351 | 37.8% |
About Dr. Amber Kyle, M.D
Dr. Amber Kyle, M.D is a Specialist healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326123233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amber Kyle, M.D has received a total of $616.34 in payments from pharmaceutical and medical device companies, with $257.15 received in 2024. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($616.34).
As a Medicare-enrolled provider, Kyle has provided services to 10,782 Medicare beneficiaries, totaling 24,138 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Torrance, CA
- Active Since 10/26/2006
- Last Updated 11/10/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326123233
Products in Payments
- DUPIXENT (Biological) $171.57
- TREMFYA (Drug) $70.89
- Sotyktu (Drug) $69.96
- REMICADE (Biological) $56.40
- SKYRIZI (Biological) $49.78
- EUCRISA (Drug) $46.42
- Otezla (Drug) $38.00
- COSENTYX (Drug) $31.13
- Apligraf (Device) $19.36
- TALTZ (Drug) $18.98
- Bimzelx (Biological) $14.80
- BOTOX COSMETIC (Biological) $12.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Torrance
Dr. William Kim, M.d, M.D
Specialist — Payments: $167,651
Specialist $167,651
Dr. Peter Borden, Md, MD
Specialist — Payments: $88,354
Specialist $88,354
Dr. Sutha Sachar, Md, MD
Specialist — Payments: $23,126
Specialist $23,126
Michael Arnstein, M.d, M.D
Specialist — Payments: $13,983
Specialist $13,983
Dr. Hala Koudsi, M.d, M.D
Specialist — Payments: $9,366
Specialist $9,366
Dr. Munish Lal, Md, MD
Specialist — Payments: $6,495
Specialist $6,495